Literature DB >> 11034804

Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma.

J Mäkelä1, H Kiviniemi, S Laitinen.   

Abstract

METHODS: Retroperitoneal soft tissue sarcomas are rare tumours. The management of these tumours has been difficult because of low resectability and a high recurrence rate. A retrospective review of a prospectively compiled database of 32 consecutive patients with retroperitoneal sarcomas treated at Oulu University Hospital between 1977 and 1996 was performed.
RESULTS: The resectability rate of primary tumours was 75%, and 44% of the patients underwent radical resection. The recurrence rate after radical resection was 57% and the resectability rate for recurrent tumours after radical primary operation, 50%. The actuarial overall 5-year survival rate was 31%, 10-year survival rate 19% and median survival 36 months. In univariate analysis the principal factors associated with prognosis were radical resection, recurrent disease, pre-operative loss of weight and histological tumour grade. Complete excision of the primary tumour was the only significant predictor of survival in multivariate analysis.
CONCLUSIONS: Complete resection of retroperitoneal sarcoma continues to be the most important prognostic factor. The inefficiency of adjuvant therapy, the high recurrence rate and the very low chance of curing the patient after recurrence make the prognosis of these patients poor. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11034804     DOI: 10.1053/ejso.2000.0945

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Major vascular resection and prosthetic replacement for retroperitoneal tumors.

Authors:  Philipp Fueglistaler; Lorenz Gurke; Peter Stierli; Tamim Obeid; Christoph Koella; Daniel Oertli; Christoph Kettelhack
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma.

Authors:  Xudong Zhao; Peiyu Li; Xiaohui Huang; Lin Chen; Na Liu; Yaoguang She
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

3.  Long-Term Quality of Life of Retroperitoneal Sarcoma Patients Treated with Pre-Operative Radiotherapy and Surgery.

Authors:  Philip Wong; Zahra Kassam; Amanda N Springer; Rebecca Gladdy; Peter Chung; Jolie Ringash; Charles Catton
Journal:  Cureus       Date:  2017-10-11

4.  Surgical Diagnosis and Treatment of Primary Retroperitoneal Liposarcoma.

Authors:  Jie Chen; Ying Hang; Qi Gao; Xinyu Huang
Journal:  Front Surg       Date:  2021-06-04

5.  Liposarcoma of the Spermatic Cord: Impact of Final Surgical Intervention--An Institutional Experience.

Authors:  R Bachmann; J Rolinger; P Girotti; H G Kopp; K Heissner; B Amend; A Königsrainer; R Ladurner
Journal:  Int J Surg Oncol       Date:  2016-04-14

6.  Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients.

Authors:  Yang Yan; Shaoyou Xia; Da Teng; Shidong Hu; Songyan Li; Yufeng Wang; Xiaohui Du; Rong Li
Journal:  Ann Transl Med       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.